News - Management, Markets & Marketing


Popular Filters

1 to 25 of 32 results

GSK comments on media coverage of China problems

GSK comments on media coverage of China problems


UK pharma giant GlaxoSmithKline, already the subject of allegations and investigations of wrongful marketing…

ChinaGlaxoSmithKlineManagementMarkets & MarketingPharmaceutical

NicOx launches commercial operations in Germany


Ophthalmology-focused French biotech firm NicOx has today announced the launch of its German operations.

AdenoPlusBiotechnologyGermanyManagementMarkets & MarketingNicOxOphthalmicsXailin

Global pharma has significant opportunities for deeper engagement with payers but contingent on restoring trust


New survey research finds that the majority payers in the USA and Europe believe that drug adherence…

EuropeManagementMarkets & MarketingPharmaceuticalPricingUSA

Actavis opens new Asia Pacific regional headquarters in Singapore


Ireland-headquartered generics major Actavis has officially opened its new regional office in Singapore…

ActavisAsia-PacificGenericsManagementMarkets & Marketing

Takeda re-aligns marketing system in Japan


Japan’s largest drugmaker Takeda Pharmaceutical says it decided to re-align its marketing system in…

Asia-PacificJapanManagementMarkets & MarketingPharmaceuticalTakeda Pharmaceuticals

Exclusive: Changing pharma marketplace means new dynamics to deal with, says Mundipharma executive


The pharmaceutical market is changing, says Georg Toufar, chief marketing officer of Mundipharma International,…

InterviewsManagementMarkets & MarketingMundipharmaPharmaceutical

Majority of pharmaceutical companies centralize market access activities


A new pharmaceutical benchmarking study found that 53% of surveyed companies centralize their market…

ManagementMarkets & MarketingPharmaceutical

Takeda sets sights on Israeli pharma market, with new subsidiary

Takeda sets sights on Israeli pharma market, with new subsidiary


Through a European subsidiary, Japan’s largest drugmaker Takeda Pharmaceuticals today announced further…

ManagementMarkets & MarketingPharmaceuticalRest of the WorldTakeda Pharmaceuticals

GlaxoSmithKline to ditch sales target-based compensation, change other global marketing practices

GlaxoSmithKline to ditch sales target-based compensation, change other global marketing practices


In the wake of the bribery scandal in China, as well as a record-breaking $3 billion fine in the USA…

GlaxoSmithKlineGlobalManagementMarkets & MarketingPharmaceutical

Japan market entry challenges – by P Reed Maurer

Japan market entry challenges – by P Reed Maurer


Not long ago, the last word in the title would have been obstacles rather than challenges, says P Reed…

Asia-PacificManagementMarkets & MarketingPharmaceutical

Eisai to double Belviq sales force by December

Eisai to double Belviq sales force by December


Eisai’s US subsidiary will increase its force for the obesity drug Belviq to around 400 representatives…

Arena PharmaceuticalsBelviqEisaiManagementMarkets & MarketingMetabolicsNorth AmericaPharmaceutical

Ono sets up subsidiary in South Korea


Japanese drugmaker Ono Pharmaceutical has decided to establish a new fully owned subsidiary in South…

Asia-PacificManagementMarkets & MarketingPharmaceutical

GlaxoSmithKline could be considering quitting China, says BBC editor


For most multinational companies, it is a no-brainer that they have to be big in China, if their global…

Asia-PacificGlaxoSmithKlineLegalManagementMarkets & MarketingPharmaceutical

Almirall sets up new affiliate to support Canadian product launches


Spain's largest pharma company, Almirall (ALM: MC) has continued its expansion with the launch of a new…

AlmirallManagementMarkets & MarketingNorth AmericaPharmaceuticalTudorza Genuair

Study highlights the steps to shape effective counter-generics strategies


More than half of pharmaceutical companies - and 71% of the largest (top 10) companies - maintain a dedicated…

GenericsManagementMarkets & MarketingPatents

Briefs: Pfizer $142 million fine upheld; Bristol-Myers shuts Amylin facility


The US Court of Appeals in Boston has upheld a $142.1 million damage award to Kaiser Foundation Health…

AmylinBristol-Myers SquibbLegalManagementMarkets & MarketingNeurontinNorth AmericaPfizerPharmaceutical

Top strategic priorities for Big Pharma marketing and sales execs in 2013; Accenture survey


Senior sales and marketing executives of large US pharmaceutical companies - with corporate revenues…

ManagementMarkets & MarketingNorth AmericaPharmaceutical

Takeda expands Latin America footprint with new subsidiary in Ecuador


Japan's largest drugmaker Takeda Pharmaceuticals (TYO: 4502) says it is expanding its presence in Latin…

ManagementMarkets & MarketingPharmaceuticalSouth AmericaTakeda Pharmaceuticals

Succeeding in Japan's pharma market - by P Reed Maurer


It appears some Western pharma executives and their consultants cannot grasp the reality of Japan's pharma…

Asia-PacificManagementMarkets & MarketingPharmaceutical

Stada Arz extends generics deal with Omega Pharma; Omega appointments


German drugmaker Stada Arzneimittel's (SAZ: GR) Belgian subsidiary, Eurogenerics, and the pharmaceutical…

EuropeGenericsManagementMarkets & MarketingOmega PharmaPharmaceuticalSTADA Arzneimittel

Watson Pharma now trading as Actavis; Dr Reddy's debuts generic Clarinex Reditabs in USA


US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) announced last week that the company has adopted…

ActavisClarinex ReditabsDr Reddy's LaboratoriesFinancialGenericsManagementMarkets & MarketingWatson Pharmaceuticals

Daiichi Sankyo and Ranbaxy combine business operations in Thailand


Japanese pharma major Daiichi Sankyo (TYO: 4568) and its 64%-owned affiliate Ranbaxy Laboratories (AB:…

Asia-PacificDaiichi SankyoGenericsManagementMarkets & MarketingPharmaceuticalRanbaxy Laboratories

Winners in Japan's Pharma market, by P Reed Maurer


The difference between winning or losing in Japan's pharma market has enormous strategic implications…

Asia-PacificManagementMarkets & MarketingPharmaceuticalResearch

Drugmakers spend an average $237,000 per medical science liaison in the USA


US-based drug companies spend an average $237,000 on each of their medical science liaisons (MSLs), but…

BiotechnologyGlobalManagementMarkets & MarketingPharmaceutical

1 to 25 of 32 results

Back to top